Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease: Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification ConsortiumBruce E. Miller, David M. Mannino, John Walsh et al.|American Journal of Respiratory and Critical Care Medicine|2016Cited by 128